Financials
- Market Capitalization 439.09 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.67
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 | OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -0.75% | -7.04% | +3.13% | +26.92% | 447.63 M USD | ||
| 2998 | BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | +1.02% | +4.80% | -22.46% | 442.48 M USD | ||
| 3007 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.43 USD | +5.19% | -0.41% | +28.57% | -28.32% | 437.61 M USD | ||
| 3020 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.43 USD | -1.09% | -13.12% | +22.30% | +348.76% | 433.33 M USD |